nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—CYP2D6—Parkinson's disease	0.673	1	CbGaD
Quinidine barbiturate—KCNK1—hindbrain—Parkinson's disease	0.00749	0.057	CbGeAlD
Quinidine barbiturate—GRIA2—hindbrain—Parkinson's disease	0.0061	0.0464	CbGeAlD
Quinidine barbiturate—KCNK1—brainstem—Parkinson's disease	0.0043	0.0327	CbGeAlD
Quinidine barbiturate—KCNK1—forebrain—Parkinson's disease	0.00415	0.0316	CbGeAlD
Quinidine barbiturate—GABRA2—hindbrain—Parkinson's disease	0.00396	0.0302	CbGeAlD
Quinidine barbiturate—GABRA1—hindbrain—Parkinson's disease	0.00383	0.0292	CbGeAlD
Quinidine barbiturate—GRIA2—embryo—Parkinson's disease	0.00381	0.029	CbGeAlD
Quinidine barbiturate—KCNK1—cardiovascular system—Parkinson's disease	0.00351	0.0267	CbGeAlD
Quinidine barbiturate—GRIA2—brainstem—Parkinson's disease	0.0035	0.0266	CbGeAlD
Quinidine barbiturate—GRIA2—forebrain—Parkinson's disease	0.00337	0.0257	CbGeAlD
Quinidine barbiturate—KCNK1—medulla oblongata—Parkinson's disease	0.003	0.0228	CbGeAlD
Quinidine barbiturate—KCNK1—midbrain—Parkinson's disease	0.00274	0.0208	CbGeAlD
Quinidine barbiturate—KCNK1—spinal cord—Parkinson's disease	0.00267	0.0203	CbGeAlD
Quinidine barbiturate—KCNK1—head—Parkinson's disease	0.00237	0.0181	CbGeAlD
Quinidine barbiturate—GABRA2—brainstem—Parkinson's disease	0.00227	0.0173	CbGeAlD
Quinidine barbiturate—KCNK1—nervous system—Parkinson's disease	0.00225	0.0171	CbGeAlD
Quinidine barbiturate—GRIA2—midbrain—Parkinson's disease	0.00223	0.017	CbGeAlD
Quinidine barbiturate—GABRA1—brainstem—Parkinson's disease	0.0022	0.0167	CbGeAlD
Quinidine barbiturate—GABRA2—forebrain—Parkinson's disease	0.00219	0.0167	CbGeAlD
Quinidine barbiturate—GRIA2—spinal cord—Parkinson's disease	0.00217	0.0165	CbGeAlD
Quinidine barbiturate—KCNK1—central nervous system—Parkinson's disease	0.00217	0.0165	CbGeAlD
Quinidine barbiturate—GABRA1—forebrain—Parkinson's disease	0.00212	0.0161	CbGeAlD
Quinidine barbiturate—KCNK1—cerebellum—Parkinson's disease	0.00212	0.0161	CbGeAlD
Quinidine barbiturate—CHRM2—forebrain—Parkinson's disease	0.00211	0.016	CbGeAlD
Quinidine barbiturate—SCN5A—cardiovascular system—Parkinson's disease	0.00209	0.0159	CbGeAlD
Quinidine barbiturate—GRIA2—head—Parkinson's disease	0.00193	0.0147	CbGeAlD
Quinidine barbiturate—GRIA2—nervous system—Parkinson's disease	0.00183	0.0139	CbGeAlD
Quinidine barbiturate—CHRM2—cardiovascular system—Parkinson's disease	0.00178	0.0136	CbGeAlD
Quinidine barbiturate—GRIA2—central nervous system—Parkinson's disease	0.00176	0.0134	CbGeAlD
Quinidine barbiturate—Quinine—CYP2E1—Parkinson's disease	0.00173	0.151	CrCbGaD
Quinidine barbiturate—GRIA2—cerebellum—Parkinson's disease	0.00172	0.0131	CbGeAlD
Quinidine barbiturate—KCNK1—brain—Parkinson's disease	0.00172	0.0131	CbGeAlD
Quinidine barbiturate—CYP2D6—hindbrain—Parkinson's disease	0.00168	0.0128	CbGeAlD
Quinidine barbiturate—Phenobarbital—GRIK2—Parkinson's disease	0.00166	0.145	CrCbGaD
Quinidine barbiturate—GABRA1—medulla oblongata—Parkinson's disease	0.00153	0.0117	CbGeAlD
Quinidine barbiturate—KCNH2—forebrain—Parkinson's disease	0.00152	0.0116	CbGeAlD
Quinidine barbiturate—Quinidine—CYP2E1—Parkinson's disease	0.00152	0.133	CrCbGaD
Quinidine barbiturate—SCN5A—head—Parkinson's disease	0.00142	0.0108	CbGeAlD
Quinidine barbiturate—Phenobarbital—CHRNA4—Parkinson's disease	0.00142	0.124	CrCbGaD
Quinidine barbiturate—GRIA2—brain—Parkinson's disease	0.0014	0.0107	CbGeAlD
Quinidine barbiturate—GABRA1—midbrain—Parkinson's disease	0.0014	0.0107	CbGeAlD
Quinidine barbiturate—GABRA1—spinal cord—Parkinson's disease	0.00137	0.0104	CbGeAlD
Quinidine barbiturate—SCN5A—nervous system—Parkinson's disease	0.00134	0.0102	CbGeAlD
Quinidine barbiturate—SCN5A—central nervous system—Parkinson's disease	0.00129	0.00985	CbGeAlD
Quinidine barbiturate—KCNH2—cardiovascular system—Parkinson's disease	0.00129	0.0098	CbGeAlD
Quinidine barbiturate—Quinine—CYP2D6—Parkinson's disease	0.00127	0.111	CrCbGaD
Quinidine barbiturate—GABRA2—head—Parkinson's disease	0.00126	0.00956	CbGeAlD
Quinidine barbiturate—GABRA1—head—Parkinson's disease	0.00121	0.00923	CbGeAlD
Quinidine barbiturate—CHRM2—head—Parkinson's disease	0.00121	0.00919	CbGeAlD
Quinidine barbiturate—GABRA2—nervous system—Parkinson's disease	0.00119	0.00906	CbGeAlD
Quinidine barbiturate—GABRA1—nervous system—Parkinson's disease	0.00115	0.00876	CbGeAlD
Quinidine barbiturate—GABRA2—central nervous system—Parkinson's disease	0.00115	0.00872	CbGeAlD
Quinidine barbiturate—CHRM2—nervous system—Parkinson's disease	0.00114	0.00871	CbGeAlD
Quinidine barbiturate—GABRA2—cerebellum—Parkinson's disease	0.00112	0.00853	CbGeAlD
Quinidine barbiturate—Quinidine—CYP2D6—Parkinson's disease	0.00111	0.0973	CrCbGaD
Quinidine barbiturate—GABRA1—central nervous system—Parkinson's disease	0.00111	0.00843	CbGeAlD
Quinidine barbiturate—CHRM2—central nervous system—Parkinson's disease	0.0011	0.00838	CbGeAlD
Quinidine barbiturate—KCNH2—medulla oblongata—Parkinson's disease	0.0011	0.00837	CbGeAlD
Quinidine barbiturate—GABRA1—cerebellum—Parkinson's disease	0.00108	0.00824	CbGeAlD
Quinidine barbiturate—SCN5A—brain—Parkinson's disease	0.00103	0.00782	CbGeAlD
Quinidine barbiturate—KCNH2—midbrain—Parkinson's disease	0.00101	0.00765	CbGeAlD
Quinidine barbiturate—KCNH2—spinal cord—Parkinson's disease	0.000981	0.00747	CbGeAlD
Quinidine barbiturate—CYP2D6—brainstem—Parkinson's disease	0.000962	0.00732	CbGeAlD
Quinidine barbiturate—CYP2D6—forebrain—Parkinson's disease	0.000928	0.00707	CbGeAlD
Quinidine barbiturate—GABRA2—brain—Parkinson's disease	0.00091	0.00692	CbGeAlD
Quinidine barbiturate—Quinine—ABCB1—Parkinson's disease	0.000905	0.0791	CrCbGaD
Quinidine barbiturate—GABRA1—brain—Parkinson's disease	0.000879	0.00669	CbGeAlD
Quinidine barbiturate—CHRM2—brain—Parkinson's disease	0.000875	0.00666	CbGeAlD
Quinidine barbiturate—KCNH2—head—Parkinson's disease	0.000872	0.00663	CbGeAlD
Quinidine barbiturate—KCNH2—nervous system—Parkinson's disease	0.000826	0.00629	CbGeAlD
Quinidine barbiturate—KCNH2—central nervous system—Parkinson's disease	0.000796	0.00606	CbGeAlD
Quinidine barbiturate—Quinidine—ABCB1—Parkinson's disease	0.000795	0.0695	CrCbGaD
Quinidine barbiturate—KCNH2—cerebellum—Parkinson's disease	0.000778	0.00592	CbGeAlD
Quinidine barbiturate—Phenobarbital—CYP2E1—Parkinson's disease	0.000687	0.06	CrCbGaD
Quinidine barbiturate—KCNH2—brain—Parkinson's disease	0.000632	0.00481	CbGeAlD
Quinidine barbiturate—CYP2D6—head—Parkinson's disease	0.000532	0.00405	CbGeAlD
Quinidine barbiturate—CYP2D6—nervous system—Parkinson's disease	0.000504	0.00384	CbGeAlD
Quinidine barbiturate—CYP2D6—central nervous system—Parkinson's disease	0.000485	0.00369	CbGeAlD
Quinidine barbiturate—CYP2D6—cerebellum—Parkinson's disease	0.000474	0.00361	CbGeAlD
Quinidine barbiturate—CYP2D6—brain—Parkinson's disease	0.000385	0.00293	CbGeAlD
Quinidine barbiturate—Phenobarbital—ABCB1—Parkinson's disease	0.00036	0.0315	CrCbGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000287	0.00156	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000287	0.00156	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—GRIN2B—Parkinson's disease	0.000287	0.00156	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—SLC6A3—Parkinson's disease	0.000283	0.00154	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000282	0.00153	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—PENK—Parkinson's disease	0.000282	0.00153	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—Parkinson's disease	0.000282	0.00153	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000281	0.00153	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000278	0.00151	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—HSPA8—Parkinson's disease	0.000276	0.0015	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000273	0.00149	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.00027	0.00147	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00027	0.00146	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000267	0.00145	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—GRIK2—Parkinson's disease	0.000267	0.00145	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—GPR37—Parkinson's disease	0.000265	0.00144	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000263	0.00143	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000262	0.00142	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000262	0.00142	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.00026	0.00141	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—DLG4—Parkinson's disease	0.000259	0.00141	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—SLC18A2—Parkinson's disease	0.000259	0.00141	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—PDYN—Parkinson's disease	0.000258	0.0014	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.000255	0.00139	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—GRIN2B—Parkinson's disease	0.000253	0.00138	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—HSPA8—Parkinson's disease	0.000253	0.00137	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—SLC6A3—Parkinson's disease	0.00025	0.00136	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.000246	0.00133	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000245	0.00133	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.000242	0.00131	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—COMT—Parkinson's disease	0.00024	0.00131	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—CHRNA4—Parkinson's disease	0.00024	0.0013	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—MAOA—Parkinson's disease	0.000239	0.0013	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—DLG4—Parkinson's disease	0.000237	0.00129	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—GRIN2B—Parkinson's disease	0.000232	0.00126	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00023	0.00125	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000228	0.00124	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.000228	0.00124	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000225	0.00122	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.000224	0.00122	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Other—HTR2A—Parkinson's disease	0.000224	0.00122	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000221	0.0012	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000221	0.0012	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—HSPA8—Parkinson's disease	0.00022	0.0012	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.00022	0.0012	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000219	0.00119	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—COMT—Parkinson's disease	0.000212	0.00115	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.000211	0.00115	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—MAOA—Parkinson's disease	0.000211	0.00114	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—DLG4—Parkinson's disease	0.000207	0.00112	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.000205	0.00111	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—CHRNA4—Parkinson's disease	0.000205	0.00111	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—GRIN2B—Parkinson's disease	0.000202	0.0011	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—GSTA4—Parkinson's disease	0.0002	0.00109	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—SLC6A3—Parkinson's disease	0.000199	0.00108	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000197	0.00107	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000195	0.00106	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—CASP3—Parkinson's disease	0.000195	0.00106	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.000189	0.00103	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—ABL1—Parkinson's disease	0.000189	0.00103	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000188	0.00102	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—HSPA8—Parkinson's disease	0.000188	0.00102	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000188	0.00102	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000187	0.00102	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000186	0.00101	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—HSPA8—Parkinson's disease	0.00018	0.00098	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—GRM4—Parkinson's disease	0.00018	0.000979	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—MAPK8—Parkinson's disease	0.000179	0.000975	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.000179	0.00097	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	0.000178	0.000968	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—HTR1A—Parkinson's disease	0.000177	0.000962	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—DLG4—Parkinson's disease	0.000176	0.000957	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.000172	0.000936	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—GRIN2B—Parkinson's disease	0.000172	0.000935	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—PENK—Parkinson's disease	0.000171	0.000928	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—SLC6A3—Parkinson's disease	0.00017	0.000922	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—DLG4—Parkinson's disease	0.000169	0.00092	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—COMT—Parkinson's disease	0.000169	0.000919	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—MAOA—Parkinson's disease	0.000168	0.000913	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000167	0.000909	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000167	0.000907	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—DRD3—Parkinson's disease	0.000166	0.000899	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—GRIN2B—Parkinson's disease	0.000165	0.000899	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.000164	0.000892	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000163	0.000886	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.000162	0.000881	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000162	0.000881	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000162	0.000879	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.000159	0.000862	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—PDYN—Parkinson's disease	0.000156	0.000849	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.000154	0.000835	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000153	0.000831	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00015	0.000816	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00015	0.000814	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—DRD2—Parkinson's disease	0.00015	0.000813	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000146	0.000791	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—GRM5—Parkinson's disease	0.000145	0.000789	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—COMT—Parkinson's disease	0.000144	0.000784	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—MAOA—Parkinson's disease	0.000143	0.000778	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.000141	0.000765	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000139	0.000756	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.000139	0.000755	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.000139	0.000755	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000139	0.000753	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GPR37—Parkinson's disease	0.000136	0.000739	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—DGKQ—Parkinson's disease	0.000136	0.000739	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000136	0.000738	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—ABL1—Parkinson's disease	0.000135	0.000733	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000132	0.000715	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000128	0.000696	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000124	0.000676	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000123	0.000671	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000121	0.000659	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	0.000121	0.000658	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000119	0.000649	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000119	0.000647	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000119	0.000647	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000118	0.000639	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GRK5—Parkinson's disease	0.000114	0.000617	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.00011	0.000599	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.00011	0.000597	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—HTR1A—Parkinson's disease	0.000107	0.000582	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000107	0.000581	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—TAC1—Parkinson's disease	0.000106	0.000573	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—DRD1—Parkinson's disease	0.000103	0.000562	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GRK5—Parkinson's disease	0.000103	0.00056	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000103	0.000558	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GRM4—Parkinson's disease	0.000102	0.000553	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—COMT—Parkinson's disease	0.0001	0.000546	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—DRD3—Parkinson's disease	0.0001	0.000545	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	9.99e-05	0.000543	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	9.97e-05	0.000542	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	9.9e-05	0.000538	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	9.85e-05	0.000535	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	9.79e-05	0.000532	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	9.73e-05	0.000529	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—VPS35—Parkinson's disease	9.7e-05	0.000527	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PENK—Parkinson's disease	9.65e-05	0.000525	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	9.53e-05	0.000518	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	9.49e-05	0.000516	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GRM4—Parkinson's disease	9.25e-05	0.000502	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	9.18e-05	0.000499	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	9.12e-05	0.000496	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—HTR7—Parkinson's disease	9.06e-05	0.000493	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—DRD2—Parkinson's disease	9.06e-05	0.000493	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	9.06e-05	0.000492	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	8.93e-05	0.000485	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—INS—Parkinson's disease	8.91e-05	0.000484	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PDYN—Parkinson's disease	8.83e-05	0.00048	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PENK—Parkinson's disease	8.77e-05	0.000476	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	8.76e-05	0.000476	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	8.62e-05	0.000469	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	8.6e-05	0.000468	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	8.57e-05	0.000466	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	8.34e-05	0.000453	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GRM5—Parkinson's disease	8.21e-05	0.000446	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DGKQ—Parkinson's disease	8.04e-05	0.000437	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GPR37—Parkinson's disease	8.04e-05	0.000437	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PDYN—Parkinson's disease	8.02e-05	0.000436	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	7.99e-05	0.000434	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	7.61e-05	0.000414	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GRM5—Parkinson's disease	7.45e-05	0.000405	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PPP1R1B—Parkinson's disease	7.35e-05	0.000399	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	7.31e-05	0.000397	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—EDN1—Parkinson's disease	7.26e-05	0.000394	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—ADORA2A—Parkinson's disease	6.98e-05	0.000379	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ND3—Parkinson's disease	6.51e-05	0.000354	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MCCC1—Parkinson's disease	6.51e-05	0.000354	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	6.45e-05	0.000351	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—RIT2—Parkinson's disease	6.42e-05	0.000349	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—HTR2A—Parkinson's disease	6.35e-05	0.000345	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—ADORA2A—Parkinson's disease	6.34e-05	0.000344	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—TNF—Parkinson's disease	6.26e-05	0.00034	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—OMD—Parkinson's disease	6.12e-05	0.000333	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TALDO1—Parkinson's disease	6.12e-05	0.000333	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GRK5—Parkinson's disease	6.09e-05	0.000331	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—HTR1A—Parkinson's disease	6.06e-05	0.000329	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—TAC1—Parkinson's disease	5.96e-05	0.000324	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—DRD1—Parkinson's disease	5.85e-05	0.000318	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	5.8e-05	0.000315	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—DRD3—Parkinson's disease	5.66e-05	0.000308	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GCH1—Parkinson's disease	5.54e-05	0.000301	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HTR1A—Parkinson's disease	5.5e-05	0.000299	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GRM4—Parkinson's disease	5.46e-05	0.000297	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—IL6—Parkinson's disease	5.46e-05	0.000296	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—TAC1—Parkinson's disease	5.42e-05	0.000294	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—DRD1—Parkinson's disease	5.31e-05	0.000289	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—ADRBK1—Parkinson's disease	5.29e-05	0.000287	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PENK—Parkinson's disease	5.18e-05	0.000281	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MAG—Parkinson's disease	5.18e-05	0.000281	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—DRD3—Parkinson's disease	5.14e-05	0.000279	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—HTR7—Parkinson's disease	5.12e-05	0.000278	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—DRD2—Parkinson's disease	5.12e-05	0.000278	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	5.05e-05	0.000274	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—FBP1—Parkinson's disease	4.93e-05	0.000268	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—DBH—Parkinson's disease	4.93e-05	0.000268	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GBA—Parkinson's disease	4.93e-05	0.000268	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—TNF—Parkinson's disease	4.83e-05	0.000262	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—ADRBK1—Parkinson's disease	4.8e-05	0.000261	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PDYN—Parkinson's disease	4.74e-05	0.000257	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—DRD2—Parkinson's disease	4.65e-05	0.000253	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HTR7—Parkinson's disease	4.65e-05	0.000253	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GFAP—Parkinson's disease	4.45e-05	0.000242	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GRM5—Parkinson's disease	4.4e-05	0.000239	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—EDN1—Parkinson's disease	4.1e-05	0.000223	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—IL6—Parkinson's disease	3.89e-05	0.000212	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FGF20—Parkinson's disease	3.86e-05	0.00021	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ADORA2A—Parkinson's disease	3.74e-05	0.000203	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—EDN1—Parkinson's disease	3.72e-05	0.000202	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—DDC—Parkinson's disease	3.62e-05	0.000197	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—HTR2A—Parkinson's disease	3.59e-05	0.000195	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—INSR—Parkinson's disease	3.46e-05	0.000188	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTA4—Parkinson's disease	3.42e-05	0.000186	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FGB—Parkinson's disease	3.27e-05	0.000177	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HTR2A—Parkinson's disease	3.26e-05	0.000177	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HTR1A—Parkinson's disease	3.25e-05	0.000177	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TAC1—Parkinson's disease	3.2e-05	0.000174	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DRD1—Parkinson's disease	3.14e-05	0.00017	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	3.08e-05	0.000167	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MAOB—Parkinson's disease	3.05e-05	0.000166	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DRD3—Parkinson's disease	3.04e-05	0.000165	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ADRBK1—Parkinson's disease	2.84e-05	0.000154	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DRD2—Parkinson's disease	2.75e-05	0.000149	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HTR7—Parkinson's disease	2.75e-05	0.000149	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	2.3e-05	0.000125	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	2.23e-05	0.000121	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.22e-05	0.000121	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	2.2e-05	0.00012	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.07e-05	0.000113	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.05e-05	0.000111	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NGF—Parkinson's disease	2.02e-05	0.00011	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TH—Parkinson's disease	2.02e-05	0.00011	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.94e-05	0.000105	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	1.92e-05	0.000105	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—APOE—Parkinson's disease	1.79e-05	9.72e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—COMT—Parkinson's disease	1.72e-05	9.33e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.71e-05	9.28e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.7e-05	9.26e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.69e-05	9.16e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.62e-05	8.79e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.57e-05	8.53e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—INS—Parkinson's disease	1.53e-05	8.31e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.5e-05	8.17e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.39e-05	7.54e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—APOE—Parkinson's disease	1.29e-05	7.02e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	1.14e-05	6.18e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	1.13e-05	6.14e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—INS—Parkinson's disease	1.1e-05	6e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	1.05e-05	5.68e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL6—Parkinson's disease	6.68e-06	3.63e-05	CbGpPWpGaD
